Table 5. Pathways associated with lncRNA DIRC3 and RMST.

Name	Size	ES	NES	NOM p-value	Gene
lncRNA DIRC3
Metabolism of xenobiotics by cytochrome P450	4	0.82	1.65	8.14E−03	CYP2S1, GSTM2, GSTA1, ADH7
Drug metabolism cytochrome P450	3	0.82	1.51	2.75E−02	GSTM2, GSTA1, ADH7
Endocytosis	3	0.74	1.50	3.37E−02	GRK7, PLD1, FGFR2
MAPK signaling pathway	2	0.64	1.31	4.14E−02	NTRK2, FGFR2
Pathways in cancer	4	0.59	1.44	4.82E−02	WNT2B, WNT5A, COL4A6, FGFR2
lncRNA RMST
Pathways in cancer	5	–0.62	–1.64	5.03E−03	WNT7B, WNT5A, COL4A6, PLD1, FGFR2
Neurotrophin signaling pathway	2	–0.76	–1.37	1.20E−02	NTRK2, CALML3
Endocytosis	4	–0.67	–1.37	1.55E−02	EPN3, GRK7, PLD1, FGFR2
Wnt signaling pathway	2	–0.52	–1.18	2.88E−02	WNT7B, WNT5A

Note:

ES, enrichment score; NES, normalized enrichment score; Nom p-value, normal p value.